iCAD has announced it has received FDA approval for use of the company's next generation mammography computer-aided detection (CAD) platform, PowerLook advanced mammography platform, with digital CAD for Philips' microdose full-field digital mammography system, according to a news release.
iCAD is a provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer.
"With this recent FDA approval, we will now be able to offer PowerLook AMP, our next generation digital mammography CAD platform, with the Philips microdose full-field digital mammography system," said Ken Ferry, CEO of iCAD, in the release. "This further broadens our partnerships with leading digital mammography companies and provides radiologists with an innovative combination of assessment tools to improve patient care."
iCAD is headquartered in Nashua, N.H.
Related Articles on FDA Clearances:
Abbott Receives FDA Approval for XIENCE Xpedition Drug Eluting Stent System
Tensys Medical Receives FDA Clearance for Hemodynamic Patient Monitoring System
Alphatec Spine Receives FDA Clearance for Anterior Cervical Interbody Device and MIS System